Eqis Capital Management, Inc. Caribou Biosciences, Inc. Transaction History
Eqis Capital Management, Inc.
- $1.19 Billion
- Q2 2025
A detailed history of Eqis Capital Management, Inc. transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 32,513 shares of CRBU stock, worth $76,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,513
Previous 34,485
5.72%
Holding current value
$76,080
Previous $31,000
29.03%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CRBU
# of Institutions
135Shares Held
43.9MCall Options Held
25KPut Options Held
53.2K-
Black Rock Inc. New York, NY6.95MShares$16.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.09MShares$9.57 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.07MShares$7.18 Million0.46% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY2.27MShares$5.32 Million0.02% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.81MShares$4.23 Million0.01% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $142M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...